Menu
Volatile organic compounds (VOCs) are olfactory biomarkers emitted by the body through breath, sweat, urine, feces, and vaginal secretions.
They are by-products of the metabolic processes within the body and form the “odorprint™” of an individual.
Your odorprint™ is a powerful tool that reflects your health status.
Just like a fingerprint, every individual has a unique odorprint™ that varies in composition and concentration. This odorprint™ is a mix of hundreds of VOCs with a very specific scent.
When an individual develops cancer, the VOC profile changes and generates a new disease scent that is common in all individuals who carry the same type of cancer.
As this scent can be detected at very early stages, patients who carry it can benefit from efficacious and less harmful treatments, with an improved quality of life.
Early cancer detection is an
urgent need. The world cannot
wait any longer.
Early cancer detection is an urgent need. The world cannot wait any longer.
Cancer mortality worldwide is constantly increasing and is projected to reach a yearly count of 18.5 million people in 2050, according to WHO.
Current detection methods have low accuracy, especially at early cancer stages, and can be highly harmful to healthy cells. These reasons prohibit them from being used as the yearly go-to screening methods.
VOC in Vocoma:
Our Approach
VOC is emerging research that will take years before it is well explored and understood. Instead of following the traditional science route that starts with research, Vocoma will primarily focus on yearly cancer screening in patients and will conduct a parallel research path to identify the VOC profile of different cancer scents.
How it Works
Sampling
VOC samples are taken from patients via breath, sweat, urine, feces or vaginal secretions in the clinical facility. This process is fast, non-invasive and pain-free.
Results
Patients receive their results for the presence or absence of the related cancer type.
Analysis
Samples are analyzed using Vocoma platform within 24h from sampling.
Follow-up
In case of positive results, patients can be assigned to specialized and competent oncologists.
Sampling
VOC samples are taken from patients via breath, sweat, urine, feces or vaginal secretions in the clinical facility. This process is fast, non-invasive and pain-free.
Analysis
Samples are analyzed using Vocoma platform within 24h from sampling.
Results
Patients receive their results for the presence or absence of the related cancer type.
Follow-up
In case of positive results, patients can be assigned to specialized and competent oncologists.
Research path: why do we research VOCs?
With its current method, Vocoma can qualitatively assess the data from patient samples and generate a binary result regarding the presence or absence of cancer.
In the future, Vocoma aims to identify the VOC profile of each cancer type to allow quantitative measurements of cancer stage and tumor growth, and expand its scent library to include all cancer types.
Vocoma AG
Oberneuhofstrasse 10,
6340 Baar, Switzerland
6340 Baar, Switzerland
Phone
Social
© Vocoma AG 2025. All rights reserved.